• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    M8, signs an exclusive agreement with SERB to bring Voraxaze to Latin America

    PR NEWSWIRE

    NCCN Issues Guideline Update on the Use of High-Dose Methotrexate, Glucarpidase

    ONCLIVE

    SERB SAS` Voraxaze (glucarpidase) Receives Approval in Europe

    EMA

    SERB receives positive CHMP opinion for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity

    PRESS RELEASE

    Initial study results show feasibility of outpatient methotrexate administration

    PRNEWSWIRE

    BTG Specialty Pharmaceuticals announces the European Medicines Agency

    PRNEWSWIRE

    Study Underway to Examine the Planned Use of Voraxaze®

    PR NEWSWIR

    BTG International`s Voraxaze (Glucarpidase) Receives Supplemental Approval in US

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.